Macrogen Corp. Announces the Inception of Macrogen Clinical Laboratory (MCL)

Macrogen Corp. Enters the Clinical Sequencing Market

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
With MCL in place, we look forward to deliver specialized service in the personalized medicine area

Rockville, MD (PRWEB) February 28, 2013

Macrogen Corporation, which provides quality DNA Sequencing services to the biotechnology and research community, announced the inception of Macrogen Clinical Laboratory (MCL) in Rockville, Maryland.

Supported by Macrogen’s excellent infrastructure and extensive experiences in NGS services, Macrogen Clinical Laboratory (MCL) is expected to receive a CLIA (Clinical Laboratory Improvement Amendments) certification to offer clinical diagnostic sequencing within the coming months.

“The inception of MCL signifies our confidence in the future of healthcare market and our adaptability to the rapidly growing demand for clinical next-generation sequencing service,” Mr. Kyung Joon Shin of Macrogen Corp. commented. “With MCL in place, we look forward to deliver specialized service in the personalized medicine area.”

About Macrogen Corporation
Macrogen Corp., a member of Macrogen Group with facilities in Asia, Europe, and the United States, is an international provider of DNA sequencing services. Macrogen Corp. provides the absolute best quality results at the fastest possible turnaround time. For additional information, please visit our website at http://www.macrogenusa.com.


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn